Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironmentElena Boggio, Umberto Dianzani, Massimiliano Garzaro et al.|British Journal of Haematology|2021Cited by 15
Neonatal Screening for Sickle Cell Disease and other Hemoglobinopathies in "The Changing Europe"Roberta Rolla, Giorgio Bellomo, Matteo Castagno et al.|Clinical Laboratory|2014Cited by 10
Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activityRiccardo Moia, Riccardo Bruna, Elena Boggio et al.|Hematological Oncology|2020Cited by 9
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patientRiccardo Bruna, Andrea Patriarca, Riccardo Moia et al.|Clinical Case Reports|2020Cited by 2